UgHerald provides the most timely and comprehensive news coverage of Uganda. It covers a wide range of fields including politics, economy, society, culture, sports, as well as in-depth analysis of international relations and important domestic events. Whether you are concerned about local developments or international influences, this is the best source for the latest information on Uganda. We are committed to helping readers understand the current situation and future of Uganda through accurate, objective and in-depth news reports, while paying attention to the challenges and development opportunities it faces.

About Us

tanzania times : Latest News and In-depth Analysis
Contact Us

Investment

HomeInvestment

All News

Mar 19, 2025

Linker Vision Showcases GenAI Innovation at GTC 2025: Advancing Sovereign AI with VLM, LVM, and Digital Twin

SAN JOSE,Calif.,March 19,2025-- Linker Vision unveils its latest advancements inSovereign AI,smart cities,and industrial AI applications at NVIDIA GTC 2025,demonstrating how its VisionAI Platform,VLM

Mar 19, 2025

Innovent and HUTCHMED Jointly Announce that the FRUSICA-2 Phase 2/3 Study of Sintilimab and Fruquintinib Combination Has Met Its Primary Endpoint in Advanced Renal Cell Carcinoma in China

SAN FRANCISCO andSUZHOU,China,March 19,2025-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high qu

Mar 19, 2025

CARsgen Announced 2024 Annual Results

SHANGHAI,March 19,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on developing innovative CAR T-cell therapies,announced its 2024 Annual Results.

Mar 19, 2025

OBAIS Marks a Historic Milestone with Nasdaq Times Square Feature, Reinforcing Its Web3 Leadership

Mar 18, 2025

Jones Day adds Corporate partner Frank Voon in Hong Kong

HONG KONG,March 17,2025--The global law firm Jones Day today announced that Frank Voon has joined the Firm as a partner in its Corporate Practice. He is based in Jones Day\'s Hong Kong Office.

Mar 18, 2025

Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer

HONG KONG,March 17,2025--Akeso Inc. (9926.HK) announced that its innovative,self-developed anti-PD-1 monoclonal antibody,penpulimab,has been officially approved by the National Medical Products Admini

1 ... 40 41 42 43 44 45 46 ... 122